Tom Kelly is the current Chief Financial Officer at zPREDICTA, and has been in this role for the past 3 years and 9 months. Prior to their current position, Kelly was the Managing Director and Head of Global Private Capital Advisory Group at The Blackstone Group for 3 years and 1 month. Tom has also held positions as Managing Director at KEMA Partners and Montgomery & Co., LLC, Principal and Head of West Coast Private Equity Placements at Bank of America, Vice President in the Private Capital Group at Robertson Stephens, and Associate in Investment Banking and Equity Research at Merrill Lynch. In their earlier career, Kelly worked as Production Manager at Weleda AG for 2 years.
Kelly has over 20 years of experience in the financial industry, with a focus on private equity and venture capital. Tom has a proven track record in raising capital for early-stage companies in the software, life sciences, and education sectors. Their experience and expertise have helped zPREDICTA become a leading provider of preclinical testing services for biotechnology and pharmaceutical companies.
Tom Kelly has an MBA from the Massachusetts Institute of Technology - Sloan School of Management, where they specialized in Financial Management. Tom also has a degree in Pharmacy from the University of Bradford, and they attended St. Jarlath's College.